23Strands is a wholly Australian owned startup focused on delivering truly personalised healthcare. Our team is dedicated to utilising whole genome sequencing and Artificial Intelligence to unlock the power of your genetic code. We combine deep phenotype and other diagnostic pathology to provide a more accurate pathway to better patient outcomes. Since 2018, 23Strands has developed a proven capability to deliver genome-wide DNA sequencing data to allow a more accurate understanding of complex diseases and to facilitate improvements in patient care.